[A peptide-based cancer vaccine composed of amino acids 264 to 272 of the wild-type protein encoded by the P53 gene. p53 peptide vaccine may elicit an HLA-A2.1-restricted cytotoxic T lymphocyte immune response against tumor cells that overexpress p53 protein. (NCI04) ( NCI )]
UMLS (NCI) C0879339P53 (264-272) peptide vaccine and tumor-specific mutant p53 peptide vaccine
p53 Peptide Vaccine
- Amino Acid, Peptide, or Protein
- Pharmacologic Substance
- Immunologic Factor